Radialis

Radialis is a medical technology company that has developed the Radialis PET Imager, an innovative organ-targeted positron emission tomography (PET) imaging system. This system utilizes thousands of modern silicon sensors placed directly next to the target area, enabling high-definition imaging of specific areas of concern. The Radialis PET Imager is designed to provide a more accurate and thorough understanding of diseases, thereby positively impacting treatment planning and decision-making.

One of the key advantages of the Radialis PET Imager is its ability to play a crucial role in precision medicine, which aims to deliver the right treatment to the right patient at the right time. For instance, the system's images could reveal whether a breast needs to be removed or conserved, whether a treatment is effective or not, and whether a high-risk individual is responding positively to treatment.

The Radialis PET Imager has been cleared by the FDA for commercial use in the US as of May 2021. It is intended for medical purposes to image and measure the distribution of injected positron-emitting radiopharmaceuticals in human beings, enabling the determination of various metabolic and physiologic functions within the body.

Radialis' technology has the potential to enable targeted early detection across a broad range of diseases. By combining high-definition imaging with safer, low-dose tracers, physicians can spot issues before they become problematic. At peak detection concentrations of radiotracer, the Radialis PET Imager collects ten times more useful imaging data than traditional state-of-the-art PET scanners, making it a promising platform for targeted early detection.

The Radialis PET Imager is designed to integrate smoothly into existing PET facilities, leveraging existing infrastructure and staffing. It has a compact footprint, measuring 2.5 feet wide, six feet long, and 4.5 feet tall, and requires only standard 120V 15A electrical service.